Live feed18:00:00·84dPRReleaseMediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patientsMNOV· Medicinova IncHealth CareOriginal source
